First Allied Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$4.94M Sell
33,345
-3,963
-11% -$613K 0.17% 137
2020
Q2
$6.13M Buy
37,308
+5,008
+16% +$769K 0.23% 104
2020
Q1
$4.48M Buy
32,300
+591
+2% +$81.2K 0.19% 122
2019
Q4
$4.17M Sell
31,709
-2,468
-7% -$286K 0.14% 170
2019
Q3
$3.83M Sell
34,177
-611
-2% -$68K 0.14% 179
2019
Q2
$3.85M Buy
34,788
+4,305
+14% +$507K 0.13% 182
2019
Q1
$3.96M Buy
30,483
+1,167
+4% +$142K 0.14% 181
2018
Q4
$3.39M Sell
29,316
-1,139
-4% -$127K 0.13% 180
2018
Q3
$3.26M Buy
30,455
+1,778
+6% +$178K 0.11% 207
2018
Q2
$2.46M Buy
28,677
+803
+3% +$66K 0.09% 244
2018
Q1
$2.16M Buy
27,874
+3,710
+15% +$299K 0.08% 262
2017
Q4
$2.04M Sell
24,164
-3,595
-13% -$306K 0.08% 265
2017
Q3
$2.37M Buy
27,759
+143
+0.5% +$11.7K 0.1% 220
2017
Q2
$2.27M Buy
27,616
+2,263
+9% +$185K 0.1% 224
2017
Q1
$2.14M Sell
25,353
-4,850
-16% -$388K 0.11% 210
2016
Q4
$2.22M Sell
30,203
-3,783
-11% -$282K 0.11% 207
2016
Q3
$2.73M Buy
33,986
+5,634
+20% +$451K 0.14% 164
2016
Q2
$2.24M Buy
28,352
+13,239
+88% +$997K 0.12% 185
2016
Q1
$1.09M Sell
15,113
-1,525
-9% -$115K 0.06% 321
2015
Q4
$1.4M Sell
16,638
-44,383
-73% -$3.68M 0.07% 289
2015
Q3
$5.11M Sell
61,021
-2,362
-4% -$199K 0.28% 92
2015
Q2
$5.29M Buy
63,383
+13,593
+27% +$1.04M 0.24% 114
2015
Q1
$3.64M Buy
49,790
+4,347
+10% +$309K 0.24% 105
2014
Q4
$3.15M Sell
45,443
-44,685
-50% -$3.02M 0.23% 104
2014
Q3
$5.82M Sell
90,128
-691
-0.8% -$43.7K 0.46% 40
2014
Q2
$5.63M Buy
90,819
+66,149
+268% +$3.95M 0.41% 49
2014
Q1
$1.45M Buy
24,670
+1,209
+5% +$67.5K 0.11% 217
2013
Q4
$1.2M Sell
23,461
-19,716
-46% -$987K 0.1% 244
2013
Q3
$2.17M Buy
43,177
+15,705
+57% +$822K 0.13% 185
2013
Q2
$1.36M Buy
+27,472
New +$1.49M 0.11% 214

Other funds holding LLY

First Allied Advisory Services's LLY Position: Q3 2020 in Review

First Allied Advisory Services reduced its Eli Lilly (LLY) stake by 11% in Q3 2020, selling an estimated $613K and leaving 33,345 shares worth $4.94M. The position accounts for 0.17% of the portfolio, ranked #137.

First Allied Advisory Services first reported a position in LLY in Q2 2013 and has held it in 30 quarters since. The position peaked at $6.13M in Q2 2020. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • First Allied Advisory Services held 33,345 shares of Eli Lilly worth $4.94M as of Q3 2020.
  • First Allied Advisory Services sold 3,963 Eli Lilly shares in Q3 2020, an estimated $613K.
  • Eli Lilly made up 0.17% of First Allied Advisory Services's portfolio in Q3 2020, its #137 holding.
  • First Allied Advisory Services first reported a position in Eli Lilly in Q2 2013 and has held it in 30 quarters since.
  • First Allied Advisory Services's Eli Lilly position peaked at $6.13M in Q2 2020.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.